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Abstract presented at the 2011 British Small Animal Veterinary Association, Birmingham, UK  
 
 
A delay in imaging following intravenous contrast medium administration has been recommended 
to reduce misdiagnoses. However, the normal variation of contrast enhancement in dogs following a 
delay has not been characterized. Contrast enhanced MR imaging of 22 dogs was assessed, in terms 
of identification of normal anatomic structures, to investigate the variation associated with 10 
minute delay between contrast medium administration and imaging. All dogs had a normal brain 
MR imaging study and unremarkable CSF. Specific ROIs were assessed both objectively, using 
computer software, and subjectively using three observers. Mean contrast enhancement greater than 
10% was seen in the pituitary gland, choroid plexus, meninges, temporal muscle, trigeminal nerve 
and the trigeminal nerve root. Structures with an active blood-brain-barrier had minimal contrast 
enhancement (<6%). Enhancing structures had significantly more contrast enhancement at t=1min 
versus t=10min, except in temporal muscle, the trigeminal nerve and the trigeminal nerve root. 
Inter-observer agreement was moderate to good in favor of  the initial post contrast T1w sequence. 
The observers found either no difference or poor agreement in identification of the non-vascular 
structures. Intra-observer agreement was very good with all vascular structures and most non-
vascular structures. A degree of meningeal enhancement was a consistent finding. The initial 
acquisition had higher enhancement characteristics and observer agreement for some structures; 
however, contrast-to-noise was comparable in the delayed phase or not significantly different. We 
provide baseline references and suggest that the initial T1w post contrast sequence is preferable but 
not essential should a delayed post contrast T1w sequence be performed. 
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Intravenous gadolinium chelates are used commonly in magnetic resonance (MR) imaging studies 
to improve contrast of normal and abnormal structures.1 Contrast enhancement results from 
alteration of the T1 and T2 relaxation time of hydrogen nuclei in the immediate vicinity of the 
gadolinium chelate.  Enhancement on T1w images appears as increasing signal intensity of tissues 
with higher concentrations of the gadolinium molecule.2 Contrast media have significant use in 
brain imaging as the normal blood brain barrier (BBB) prevents gadolinium extravasation. 
Therefore lesions affecting the BBB often have increased intensity after gadolinium administration.3 
The dose related,4,5 time-dependent5-8 and pulse technique9,10 differences in contrast enhancement 
have been quantified.  Mean peak signal enhancement varies depending on the tissue or lesion. 
Some intracranial lesions have no enhancement immediately following contrast medium 
administration.3,11-13 A delay period following administration has, therefore, been recommended to 
allow gadolinium to accumulate in pathologic tissues.3,11 The majority of animals are anaesthetised 
during MR imaging and a delay following contrast medium administration is not typical. Our aim 
was to characterize the difference in post contrast T1-weighted images of the normal brain when 
allowing a 10 min delay between administration of contrast medium and image acquisition. 
 
 
Materials & Methods: 
Dogs undergoing a brain MR imaging examination between December 2009 and April 2010 but 
without haematologic, serum chemistry and cerebrospinal fluid (CSF) abnormalities were 
evaluated. Dogs were not included if there were signs of a cranial nerve deficit or intracranial 
lesions were present on the MR image, if a delayed phase scan was unobtainable due to anaesthetic 
reasons, or if noticeable movement occurred between the transverse sequences.  Twenty-two dogs 
were identified. Age ranged from 8 months to 10 years, with a mean of 4.4 years. Five of 12 males 
were intact and three of 10 females were entire. The majority were mix breed dogs (N=4), Labrador 
retrievers (N=3), Dalmatians (N=2), Jack Russell terriers (N=2), Shih-Tzus (N=2) and Boxers 
(N=2). 
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 Dogs were anaesthetised for imaging using IV propofol (Propoflo; Abbott Laboratories, 
Berkshire) and maintained on isoflurane (Isoflo, Abbott Laboratories, Berkshire) in oxygen. 
Gadopentetate dimeglumine (Gd-DTPA)  (Magnevist, Bayer plc, Newbury, Berkshire) was used as 
a contrast medium at 0.2mg/kg. 
All images were acquired while the patient was in dorsal recumbency using a 1.5 Tesla unit 
(Siemens Magnetom Essenza, Siemens AG, Erlangen, Germany) with a human head/neck coil. T2w 
sagittal, dorsal and transverse; FLAIR transverse; T2* transverse and T1w transverse sequences 
were acquired in all dogs. T1-weighted transverse sequences were repeated immediately following 
contrast medium administration and again 10 minutes later (TR = 455-674ms, TE = 13). Standard 
slice thickness was either 3mm or 4mm for transverse plane images depending on patient size.  
Enhancement characteristics of both contrast T1w sequences were assessed objectively 
using ROIs and subjectively involving three observers (RN, MS & GH) who were unaware of the 
timing of contrast medium administration.   
For objective assessment, both sequences were analysed using a DICOM image viewer 
(OsiriX version 3.7; OsiriX Imaging Software).  Regions of interest (ROIs) were selected to include 
the following structures: pituitary gland, choroid plexus of the lateral ventricles, meninges, temporal 
muscle, thalamus, cerebral cortex, white matter, hippocampus, trigeminal nerve and root, the 
piriform lobe and external air space (Figure 1). For identifying the different tissues of the brain, the 
ROIs were generated using the T2 transverse series and then extrapolated to all three T1-weighted 
sequences using point based registration. The ROI assigned to the external airspace, within the field 
of view, was used to determine signal noise measurements. For each ROI the mean signal intensity 
and standard deviation were recorded as arbitrary units.  
Based on the ROIs measurements the signal-to-noise ratio (SNR), the contrast-to-noise ratio 
(CNR) and the enhancement percentage (E%), were calculated as follows: 87 
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SNR = (SItissue/SDair) 
CNR = (SItissue– SIwm)/SDair 
% enhancement = SIpost – SIbaseline 91 
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SIpost - mean tissue signal intensity at specified time after contrast administration; SIBaseline  - 
mean tissue signal intensity before contrast; SDair  - standard deviation of background signal 
(average if comparing pre and post sequences);  SItissue  - mean signal intensity of tissue to 
contrast with SIwm - mean signal intensity of white matter. 
 
 
For subjective assessment two board certified radiologists and one final year radiology 
resident were given all three T1w series for each of the 22 dogs. The pre contrast T1w image was 
given as a known control; however, the two post contrast T1w series were randomized (Figure 2). 
Each observer was asked to choose the series with the best visualization of the aforementioned 
structures or state there was no difference. To calculate intra-observer variability, the same 
assessment was repeated 2 weeks later, but with patient order and the T1w post contrast series 
layout randomized. At no time was the DICOM header or metadata information available to 
observers.    
 
All data is shown as mean ± standard deviation. Respective data for SNR, CNR and E% of 
both post contrast series were analysed using 2-tailed Student paired t tests. Where one or both pairs 
of comparison data were not distributed normally a non-parametric sign rank (Wilcoxon matched 
pairs) test was used. Results of relevant differences in SNR, CNR and E% were tabulated with 
calculation of standard deviations and P values. A P value of <0.05 was considered statistically 
significant. For inter and intra rater assessment Gwet's alternative coefficient (AC1)
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14 was used and 
significance defined by the agreement measures for categorical data.15  
 
 
Results: 
There was n 
o significant difference between baseline SNR and either the initial or delayed post contrast series 
for white matter, thalamus, and piriform lobe. The cerebral cortex and hippocampus were 
characterized by a significant difference between the baseline and the initial SNR, but not the 
delayed post contrast series (Figure 3). Mean enhancement percentages greater than 10% were seen 
in pituitary gland, choroid plexus, meninges, temporal muscle, trigeminal nerve and trigeminal 
nerve root. For both the 1 and 10 minute scans respectively, trigeminal nerve showed the most 
enhancement (57.5±11.4%, 53.7±13.9%), followed by the pituitary (54.9±19.6%, 38.4±19.9%), 
meninges (32.9±14.6%, 24.2±12.7%), choroid plexus (29.7±10.1%, 22.5±8.5%) temporal muscle 
(20.8±5.8%, 19.8±4.8%) and trigeminal nerve root (13.0±6.9%, 14.6±10.9%) (Figure 4). These 
structures all showed significantly more contrast enhancement at t=1min versus t=10min (p<0.05), 
except the temporal muscle, trigeminal nerve and trigeminal nerve root. The other structures had 
minimal enhancement (mean enhancement percentage <6%).   
For CNR calculations, the white matter ROI was used as, in retrospect, it had the least 
enhancement percentage following contrast medium administration for both the 1 and 10 minute 
delayed series; 1.6±1.1% and 1.1±1.5% respectively.  For structures with an enhancement 
percentage above 10%, the increase in CNR for the 1 and 10 minute scans respectively were: 
pituitary (30.3±12.1 & 20.7±11.6), choroid plexus (12.0±5.3 & 9.0±3.9), meninges (11.0±5.5 & 
7.8±4.3), muscle (7.0±2.8 & 6.9±2.3), trigeminal nerve (24.2±7.2 & 22.7±8.2), trigeminal nerve 
root (4.4±2.4 & 5.3±4.4) (Figure 5).   
 139 
140 
141 
142 
143 
144 
145 
146 
147 
148 
149 
150 
151 
152 
153 
154 
155 
156 
157 
158 
159 
160 
161 
162 
163 
164 
Inter-observer agreement was moderate to substantial in favor of the the initial post contrast 
sequence for the pituitary, choroid plexus and the meninges. Inter-observer agreement was 
substantial to almost perfect for hippocampus, thalamus and piriform lobe in favor of no difference 
being observed between both post contrast sequences. Inter-observer agreement was poor for the 
muscle, cerebral cortex, white matter, trigeminal nerve and the trigeminal nerve root.  Intra-observer 
agreement was substantial to almost perfect in favor of the initial post contrast sequence for the 
pituitary, choroid plexus and meninges and, for observer 1, white matter. Observer 1 had substantial 
agreement for muscle in favor of the delayed post contrast images whereas the other two observers 
had almost perfect agreement for no difference between post contrast images. All other remaining 
tissues either had substantial-almost perfect agreement in favor of no difference between post 
contrast sequences or only slight agreement with no favoring between post contrast sequences. 
 
Discussion: 
 
All forebrain structures had minimal contrast enhancement (<6%) which is due to the highly 
selective blood brain barrier (BBB).16  Inter and intra-observer agreement for identifying these 
structures was either poor or highly favoring no difference between the post contrast series. When 
assessing the conspicuity of white matter, however, Observer 1 had high intra-observer agreement 
favoring the initial and delayed contrast series equally rather than no difference.  We do not know 
why this observer's agreement was high as the SNR and enhancement characteristics were 
comparable to that of the most adjacent structures e.g. thalamus, which had poor inter and intra-
observer agreement or leniency towards no difference. We conclude, however, that the overall equal 
leniency towards both post contrast sequences is clinically comparable to the other two observers 
finding no difference between them. The CNR for forebrain structures had a substantial increase for 
both post contrast phases; however, based on the relatively low enhancement values and low 
agreement it is likely that these changes are not detectable and ultimately not clinically relevant.   165 
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Gadolinium uptake will be detected in structures with high vascularity e.g. pituitary gland; 
lateral, 3rd and 4th ventricles of the brain, choroid plexus and venous sinuses of the cranial dura 
mater,14 or where there is increased vascular permeability.17  
The pituitary gland had a large degree of contrast enhancement for both the initial and 
delayed contrast sequences. The vascular supply to the pituitary gland is supplied directly from the 
internal carotid artery via the caudal hypophyseal artery to the neurohypophysis, and indirectly by 
the portal pituitary system.18 Both vascular phases appear separately leading to a distinct pituitary 
flush from the neurohypophysis followed by homogenous contrast enhancement. Using dynamic 
MR and CT imaging the entire pituitary gland exhibits peak homogenous contrast enhancement at 
60-90 seconds following contrast medium administration before gradually returning to the 
baseline.18,19 We imaged the pituitary gland during this 60-90 second window and again 
approximately 10 minutes later, revealing a larger increase in CNR for the initial series. The 
difference in CNR between the two post contrast phases was supported by the high intra and inter-
observer agreement favoring the initial post contrast series. The delayed series still jad a mean 
increase of 474% in CNR from the baseline. 
The choroid plexus had similar enhancement characteristics to the pituitary gland. There is 
similarity of anatomy of microvascular structures between the rat, dog and human identifying the 
arterial supply via the choroidal arteries, which originate from the internal carotid artery.20,21 As the 
choroid plexus is intrinsically highly vascular, there was an xpected increase in contrast 
enhancement following contrast medium administration. Like the pituitary gland, the reduction in 
contrast enhancement in the delayed phase was supported by the high intra and inter-observer 
agreement favoring the initial post contrast series. This was observed despite only a 28.7% 
difference in CNR between the two post contrast series. 
 
Meningeal enhancement in veterinary neuroimaging is described as meningeal disease22,23 
however, human neuroimaging publications describe a small amount of meningeal contrast 
enhancement as a normal finding as a result of normal vascularity.
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24-26 We found a small amount of 
enhancement, appearing as short thin meningeal segments, in all 22 dogs (Figure 6). CNR was 
higher for the initial phase than the delayed phase, despite only differing by 24.3%. This was 
supported by substantial inter and intra-observer agreement in favor of the initial post contrast 
series.  
Conspicuity of meningeal enhancement can be heightened by increasing the volume of 
injected contrast medium, reducing the slice thickness, selecting an optimal plane of section, using 
post contrast FLAIR sequences or by using fat suppressed spin echo sequences.25,27-29 With regards 
to post contrast FLAIR sequences the degree of enhancement can be variable as the effects of 
gadolinium lead to increased T1w signal, but decreased T2w; both of which contribute to FLAIR 
images. Enhancement in FLAIR images may ultimately depend on the concentration of gadolinium 
within specific tissue.27,29
Others have found that canine p 
araspinal muscle enhancement reached approximately 6% at 1 minute, 22% at 4 minutes, 
16% by 10 minutes and then slowly declined over 45 minutes.30 We found similar enhancement 
percentages but no significant difference between the initial and delayed series. The selection of 
image slice to determine muscle enhancement was not based on anatomic location but rather the 
slice having the largest cross sectional area of muscle without enhancing vasculature. For this 
reason, the specific acquisition time may vary more than for other ROIs, which were determined by 
the slice that best represented the anatomy. It is likely that this variability was responsible for the 
similar enhancement characteristics between both post contrast series. Muscle has a relatively small 
extracellular space, which does not allow the same sequestration of contrast medium as for other 
tissues.17 The permeability of the capillary endothelial cells in muscle occurs via tight junctions and 
intracellular gaps; however, the transfer of contrast medium is largely unidirectional.30,31,32 This 
would explain the lower enhancement characteristics and longer contrast washout of muscle 
compared to the other vascular structures in our study. Based on objective analysis of temporal 
muscle enhancement, there was no significant difference in the enhancement percentage and CNR. 
Intra-observer agreement was almost perfect; however, the initial post contrast series was favored 
by one observer becauseenhancing vessels within muscle was more distinct in the initial post 
contrast series. The other 2 observes felt the muscle was not different between the two series.  
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 Trigeminal nerve enhancement isa normal finding in canine patients without clinical signs of 
trigeminal nerve disease.33,34  The proposed mechanism for the enhancement is an incomplete 
blood-nerve barrier.35,36 Trigeminal nerve enhancement was identified in all 22 dogs. We found 
more enhancement of the trigeminal nerve than in the pituitary gland; this is contradictory to prior 
work (REF). The lower E% of the pituitary gland is likely a reflection of the higher baseline SNR of 
the pituitary gland on T1w images (Figure 2A) due to signal from arginine vasopressin.35 The 
difference in CNR for the trigeminal nerve between both post contrast series was not significantly 
different. This is supported by the poor inter-observer agreement. Overall intra-observer agreement 
was lowest for the trigeminal nerve with observers 1 & 2 having fair agreement. Observer 3 had 
moderate agreement; however, this was in favor of no difference between the post contrast series. 
 
The trigeminal nerve root was the only ROI with higher mean enhancement in the delayed phase. 
The enhancement percentage and CNR for each post contrast series was; however, not significantly 
different. Subjective assessment supported this finding through poor inter and intra-observer 
agreement or leniency towards no difference between the the post contrast series. For consistency 
the CNR was based on the enhancement properties of white matter; no other structures from the 
brain stem were assessed for contrast enhancement. Therefore, the larger enhancement percentage 
and CNR between the trigeminal nerve root and forebrain may reflect the difference in vascularity 
or higher dependency on the basilar artery for brain stem vascular supply; particularly the 
trigeminal nerve root.37  
 We did not have histologic confirmation of brain normality but the MR images and CSF 
analysis were normal. Micro-motion or positional relaxation between the two post contrast series 
may have led to ROI registration errors.  Also, we cannot guarantee that each slice chosen to 
represent each ROI occurred at the same time as the number of slices and starting position of each 
slice varied between patients. This may reflect the larger distribution of enhancement data.  
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 In conclusion, there was variable enhancement of intrinsically vascular permeable tissues 
and some changes in enhancement were noted following an approximate 10 minute delay in 
acquisition. Although the initial acquisition had higher enhancement characteristics and observer 
agreement for some structures, CNR were comparable in the delayed phase or not significantly 
different. In addition, other structures had either comparable enhancement characteristics or low 
inter and intra-observer agreement between the two post contrast phases. With many intracranial 
structures and lesions having variable contrast enhancement, or lack thereof, when using an 
immediate post contrast sequence,12,13 performing a delayed post contrast sequence may allow for 
improved lesion conspicuity. We provide baseline references and suggest that the initial T1w post 
contrast sequence is preferable but not essential should a delayed post contrast T1w sequence be 
performed. 
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Figure 1) Transverse T2w images of the head. A; Temporal muscle, hippocampus, cerebral cortex 
and trigeminal nerve root. B; Pituitary gland. C; Thalamus and trigeminal nerve. D; White matter, 
meninges, choroid plexus and piriform lobe. Note; External air ROI is not shown in these images 
 
Figure 2) Three transverse T1w images of the same patient at the same level. A is the pre contrast 
image. B is the immediate post contrast image. C is the delayed post contrast image. Note the signal 
intensity of the pituitary gland in each image (arrowheads). 
 
Figure 3) Signal-to-Noise Ratio for each T1w series: Pre-contrast (grey), initial post contrast (white) 
and delayed post contrast (striped). Asterisk denotes no significant difference (p>0.05) between 
each T1w series. 
 
Figure 4) Enhancement percentage for each post contrast series: Initial and delayed. Asterisk 
denotes no significant difference (p>0.05). 
 
Figure 5) Contrast-to-noise ratio (difference) for each post contrast series: Initial (striped) and 
delayed (white). Asterisk denotes no significant difference (p>0.05). 
 
Figure 6) T1w transverse digital subtraction image using the pre-contrast image and the initial post-
contrast image. Note the thin meningeal contrast enhancement (arrow). 
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